Home / Inspections / 1009137

FDA Inspection 1009137 — Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals, Inc. — FEI 3002936358

The FDA completed an inspection of Amphastar Pharmaceuticals, Inc. on March 31, 2017 in Rancho Cucamonga, CA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Devices.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
March 31, 2017
Fiscal Year
2017
Product Type
Devices
Project Area
Compliance: Devices
Location
Rancho Cucamonga, CA (United States)

Facility

Other inspections at this facility

  • 1266798 (NAI Thu Apr 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1229403 (VAI Fri Mar 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1144508 (NAI Tue Jun 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1113865 (NAI Fri Nov 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1115634 (NAI Thu Nov 21 2019 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources